Regulatory Considerations for Shelf Life Extension Requests
Extending the shelf life of pharmaceutical products—whether due to improved stability data, supply chain challenges, or repurposing—is a regulatory-sensitive process. Authorities like the USFDA, EMA, and CDSCO have well-defined frameworks for shelf life extension, typically requiring updated stability data and robust justifications. This article explores the regulatory considerations and strategic planning required for submitting shelf…
Read More “Regulatory Considerations for Shelf Life Extension Requests” »